Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study-Reference-Cited by-同舟云学术

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

Published:2005-05 Issue:5 Volume:6 Page:279-286
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Moroni Mauro,Veronese Silvio,Benvenuti Silvia,Marrapese Giovanna,Sartore-Bianchi Andrea,Di Nicolantonio Federica,Gambacorta Marcello,Siena Salvatore,Bardelli Alberto

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Systemic therapy for colorectal cancer;Meyerhardt;N Engl J Med,2005

2. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor;Saltz;J Clin Oncol,2004

3. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

4. ABX-EGF monotherapy in patients (pts) with metastatic colorectal cancer (mCRC): an updated analysis;Hecht;Proc Am Soc Clin Oncol,2004

5. Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs;Ciardiello;Eur J Cancer,2003

Cited by 852 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics;Protein Science;2024-09-14

2. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance;International Journal of Molecular Sciences;2024-06-28

3. Detecting EGFR gene amplification using a fluorescence in situ hybridization platform based on digital microfluidics;Talanta;2024-03

4. Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023);Expert Opinion on Therapeutic Patents;2024-02

5. Molecular testing in colorectal cancer;Diagnostic Molecular Pathology;2024